Claret Asset Management Corp Takeda Pharmaceutical CO LTD Transaction History

Claret Asset Management Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 06, 2020	SELL	$14.59 - $19.5 $148,088 - $197,925	-10,150 Closed	0 $0
Q1 2020 Apr 06, 2020	SELL	$13.02 - $20.31 $17,303 - $26,991	-1,329 Reduced 11.58%	10,150 $154,000
Q4 2019 Jan 07, 2020	SELL	$16.88 - $20.83 $52,716 - $65,052	-3,123 Reduced 21.39%	11,479 $226,000
Q3 2019 Oct 11, 2019	SELL	$16.15 - $17.99 $32,009 - $35,656	-1,982 Reduced 11.95%	14,602 $251,000
Q2 2019 Jul 24, 2019	SELL	$16.58 - $20.49 $56,090 - $69,317	-3,383 Reduced 16.94%	16,584 $294,000
Q1 2019 Apr 29, 2019	BUY	$16.7 - $21.52 $333,448 - $429,689	19,967 New	19,967 $407,000

323

70.5M

939K

233K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $43.4B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Claret Asset Management Corp, based on Form 13F filings with the SEC.

Stay updated on Claret Asset Management Corp with notifications on news.